Showing results (121-130 of 192) with videos related to
Sort By:
Pageof 20
The Journal of Infectious Diseases|November 1, 1983
Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infectionC I Smith, J Weissberg, L Bernhardt, et al.Expert Opinion on Pharmacotherapy|December 2, 2004
Current chemotherapeutic treatment of malignant pleural mesotheliomaAnna K Nowak, Michael J Byrne, Michael J Millward, et al.Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences|January 1, 1985
Molecular cloning and characterization of the cDNA coding for hepatitis B virus surface antigenB G He, J L Melnick, A Siddiqui, et al.Lung Cancer (Amsterdam, Netherlands)|March 15, 2011
Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?Jenette Creaney, Deborah Yeoman, Arthur William Musk, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1984
Liver disease associated with duck hepatitis B virus infection of domestic ducksP L Marion, S S Knight, B K Ho, et al.JAMA|April 23, 1982
Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infectionC I Smith, L W Kitchen, G H Scullard, et al.The New England Journal of Medicine|September 2, 1976
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitisH B Greenberg, R B Pollard, L I Lutwick, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesotheliomaJenette Creaney, Deborah Yeoman, Yvonne Demelker, et al.Antimicrobial Agents and Chemotherapy|February 1, 1985
Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymeraseD F Smee, S S Knight, A E Duke, et al.Antimicrobial Agents and Chemotherapy|January 1, 1982
Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combinationS L Sacks, G H Scullard, R B Pollard, et al.Pageof 20